Coldstream Capital Management Inc Catalyst Pharmaceuticals, Inc. Put Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CPRX
# of Institutions
381Shares Held
96.5MCall Options Held
29.2KPut Options Held
22.8K-
Black Rock Inc. New York, NY18.7MShares$454 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$206 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$134 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$76.2 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$76.1 Million1.62% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.5B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...